{"transactions":[{"id":975110,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:30:00.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026."}],"balance_after":140000,"derivative":{"exercise_price":0.35,"expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001064901-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490125000002/primary_doc.xml","form_type":"4"}},{"id":1138018,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:56:32.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":144445},"source":{"system":"sec-edgar","filing":"0001345281-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000003/primary_doc.xml","form_type":"4"}},{"id":1138017,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:56:32.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":144445,"price":0.09,"value":13000.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1473467,"source":{"system":"sec-edgar","filing":"0001345281-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000003/primary_doc.xml","form_type":"4"}},{"id":1342022,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-05T17:41:50.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.34,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001064901-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490124000001/primary_doc.xml","form_type":"4"}},{"id":1353166,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T22:08:54.000Z","date":"2024-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55555,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144445,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":55555},"source":{"system":"sec-edgar","filing":"0001345281-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000006/primary_doc.xml","form_type":"4"}},{"id":1353165,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-25T22:08:54.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":55555,"price":0.09,"value":4999.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1329022,"source":{"system":"sec-edgar","filing":"0001345281-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000006/primary_doc.xml","form_type":"4"}},{"id":1728016,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T23:31:12.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.26,"expiration_date":"2033-11-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000008/primary_doc.xml","form_type":"4"}},{"id":1775783,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775782,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."}],"balance_after":21667,"derivative":{"exercise_price":1.045,"exercise_date":"2022-11-03","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775781,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date."}],"balance_after":66667,"derivative":{"exercise_price":0.72,"exercise_date":"2021-11-04","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775780,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25,000 vested on May 24, 2019 and in 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022."}],"balance_after":150000,"derivative":{"exercise_price":0.23,"exercise_date":"2019-05-24","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775779,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T19:41:26.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1273467,"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775778,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3410512,"price":0.4,"value":1364204.8,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay."}],"balance_after":3410512,"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1872497,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T18:38:37.000Z","date":"2023-05-30","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0.34,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Common Stock on date of gift, May 30, 2023."}],"balance_after":1811800,"source":{"system":"sec-edgar","filing":"0001064901-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000001/primary_doc.xml","form_type":"4"}},{"id":2120343,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:53:39.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001064901-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490122000001/primary_doc.xml","form_type":"4"}},{"id":2527183,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:25:02.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001064901-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490121000001/primary_doc.xml","form_type":"4"}},{"id":2971693,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T21:40:08.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on November 4, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.65,"expiration_date":"2030-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000003/primary_doc.xml","form_type":"4"}},{"id":3509220,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-29T20:26:54.000Z","date":"2019-05-24","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020."}],"balance_after":250000,"derivative":{"exercise_price":0.21,"expiration_date":"2029-05-24","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001064901-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490119000001/primary_doc.xml","form_type":"4"}},{"id":3725398,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-12-20T00:01:54.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":50000,"price":0.14,"value":7000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"50,000 common stock shares acquired upon exercise of stock option grant dated January 23, 2009."}],"balance_after":1423467,"source":{"system":"sec-edgar","filing":"0001064901-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490118000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-19"}},{"id":3725394,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2018-12-19T22:54:39.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":50000,"price":0.14,"value":7000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"50,000 common stock shares acquired upon exercise of stock option grant dated January 23, 2009."}],"balance_after":1173467,"source":{"system":"sec-edgar","filing":"0001064901-18-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490118000001/primary_doc.xml","form_type":"4"}}]}